Background: Dietary fibers are metabolized by gastrointestinal (GI) bacteria into short-chain fatty acids (SCFAs). We investigated the potential role of these SCFAs in β-amyloid (Aβ) mediated pathological processes that play key roles in Alzheimer’s disease (AD) pathogenesis. Research design and methods: Multiple complementary assays were used to investigate individual SCFAs for their dose-responsive effects in interfering with the assembly of Aβß1-40 and Aβ1-42 peptides into soluble neurotoxic Aβ aggregates. Results: We found that several select SCFAs are capable of potently inhibiting Aβ aggregations, in vitro. Conclusion: Our studies support the hypothesis that intestinal microbiota may help protect against AD, in part, by supporting the generation of select SCFAs, which interfere with the formation of toxic soluble Aβ aggregates

Ho, L., Ono, K., Tsuji, M., Mazzola, P., Singh, R., Pasinetti, G. (2018). Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimerâ s disease-type beta-amyloid neuropathological mechanisms. EXPERT REVIEW OF NEUROTHERAPEUTICS, 18(1), 83-90 [10.1080/14737175.2018.1400909].

Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms

Mazzola, P;
2018

Abstract

Background: Dietary fibers are metabolized by gastrointestinal (GI) bacteria into short-chain fatty acids (SCFAs). We investigated the potential role of these SCFAs in β-amyloid (Aβ) mediated pathological processes that play key roles in Alzheimer’s disease (AD) pathogenesis. Research design and methods: Multiple complementary assays were used to investigate individual SCFAs for their dose-responsive effects in interfering with the assembly of Aβß1-40 and Aβ1-42 peptides into soluble neurotoxic Aβ aggregates. Results: We found that several select SCFAs are capable of potently inhibiting Aβ aggregations, in vitro. Conclusion: Our studies support the hypothesis that intestinal microbiota may help protect against AD, in part, by supporting the generation of select SCFAs, which interfere with the formation of toxic soluble Aβ aggregates
Articolo in rivista - Articolo scientifico
Alzheimer's disease; beta-amyloid; fibrils; microbial; microbiome; microbiota; neurodegeneration; protein misfolding; Neuroscience (all); Neurology (clinical); Pharmacology (medical)
English
14-nov-2017
2018
18
1
83
90
open
Ho, L., Ono, K., Tsuji, M., Mazzola, P., Singh, R., Pasinetti, G. (2018). Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimerâ s disease-type beta-amyloid neuropathological mechanisms. EXPERT REVIEW OF NEUROTHERAPEUTICS, 18(1), 83-90 [10.1080/14737175.2018.1400909].
File in questo prodotto:
File Dimensione Formato  
Protective roles of intestinal microbiota in AD-Exp Rev Neurother 2017.pdf

Accesso Aperto

Descrizione: Articolo principale
Dimensione 1.64 MB
Formato Adobe PDF
1.64 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/186470
Citazioni
  • Scopus 239
  • ???jsp.display-item.citation.isi??? 210
Social impact